Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06118892 · ClinicalTrials.gov registry record · NA
MISHA Post-Market Clinical Study
A NA study of Osteoarthritis, Knee, sponsored by Moximed.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 3
- Study locations
NCT06118892: Recruiting NA study of Osteoarthritis, Knee, sponsored by Moximed.
NCT06118892 is a NA study of Osteoarthritis, Knee that is actively recruiting participants, run by Moximed. The registered enrollment target is 120 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (76% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06118892, a NA study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by Moximed.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 3
- Study locations
Study Summary
Prospective evaluation of the safety and effectiveness of the MISHA Knee System. The study will collect data on the procedural and long-term adverse events, WOMAC pain and function scores, KSS satisfaction, subsequent surgical interventions, BMI levels, range of motion, UCLA activity level of the subjects, and perform radiographic/x-ray evaluations at clinical visits through 5 years post-procedure. The primary analysis of this study is freedom from device- and procedure-related SSIs at five (5) years post-implantation. This study will also assess device performance in subjects with intact and retained devices and subjects with devices removed prior to study termination and freedom from conversion to arthroplasty through 5 years. Study subjects will be followed over a five-year post-implant period.
Conditions Studied
Interventions
- DEVICE MISHA Knee System
Study Locations (3)
California
- Weiss Orthopedics - Sonoma
Oregon
- Oregon Health and Science University - Portland
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-11-03 |
| Est. Completion | 2030-07-30 |
| Phase | NA |
What NCT06118892 shows while recruiting
NCT06118892 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which MISHA Knee System is the first listed.
NCT06118892 reports a single indexed study location in California, Oregon, Virginia.
Frequently Asked Questions
What is clinical trial NCT06118892 about?
NCT06118892 is a clinical study titled "MISHA Post-Market Clinical Study". Prospective evaluation of the safety and effectiveness of the MISHA Knee System. The study will collect data on the procedural and long-term adverse events, WOMAC pain and function scores, KSS satisfaction, subsequent surgical interventions, BMI levels, range of motion, UCLA activity level of the s...
What is the current status of trial NCT06118892?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-11-03. Estimated completion is 2030-07-30.
What conditions does trial NCT06118892 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT06118892?
The interventions under investigation include: MISHA Knee System (DEVICE).
Who is sponsoring clinical trial NCT06118892?
This trial is sponsored by Moximed, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06118892 being conducted?
This trial has 3 study locations across California, Oregon, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06118892's enrollment target sits among peer trials
120 55th of 112 higher than 55 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobilizing Hispanics With Knee Osteoarthritis
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
The Osteoarthritis Prevention Study
RECRUITING · NA
-
Navio Robotic Versus Conventional Total Knee Arthroplasty
RECRUITING · NA
-
MOTION Clinical Trial
RECRUITING · NA
-
Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI